US Stock MarketDetailed Quotes

Vaxcyte (PCVX)

Watchlist
  • 59.210
  • -0.330-0.55%
Close Sep 15 15:59 ET
8.81BMarket Cap-7.76P/E (TTM)

Vaxcyte (PCVX) Earnings Dates, Reports & Conference Call

PCVX 2026 Q2 Estimated Earnings Dates & Summary

Currency:USD--

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Net Income
-298.28M
-284.30M
13.98M
Beat Est.
-79.07%
-70.68%
+4.69%
EPS
-2.103
-1.97
+0.133
Beat Est.
-72.34%
-61.48%
+6.30%
Strong Buy

Aug 31, 2026

PCVX Revenue, EPS and EBIT Estimates

Revenue

Net Profit

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/Q4-- / 0.000--
--2026/Q3-- / 0.000--
--2026/Q20.000 / 0.000--
--2026/Q10.000 / 0.000--
Feb 24, 20262025/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2026/Q4-- / 0.000--
--2026/Q3-- / 0.000--
--2026/Q20.000 / 0.000--
--2026/Q10.000 / 0.000--
Feb 24, 20262025/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On September 1, U.S. Eastern Time, the U.S. military launched a new round of strikes against Iran in response to recent attempts by the Isla Show More